Nektar Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results

/PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the fourth quarter and full year ended December 31, 2022. Cash and...

Related Keywords

California ,United States ,Alabama ,San Francisco ,David Rosen ,Howardw Robin ,Vivian Wu ,Exchange Commission On ,Nektar Therapeutics ,Annual Report ,Exchange Commission ,